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Abstract
Background: Cruciferous vegetable intake is inversely associated with the risk of several cancers. Isothiocyanates
(ITC) are hypothesized to be the major bioactive constituents contributing to these cancer-preventive effects. The
polymorphic glutathione-S-transferase (GST) gene family encodes several enzymes which catalyze ITC degradation
in vivo.
Methods: We utilized high throughput proteomics methods to examine how human serum peptides (the
“peptidome”) change in response to cruciferous vegetable feeding in individuals of different GSTM1 genotypes. In
two randomized, crossover, controlled feeding studies (EAT and 2EAT) participants consumed a fruit- and
vegetable-free basal diet and the basal diet supplemented with cruciferous vegetables. Serum samples collected at
the end of the feeding period were fractionated and matrix assisted laser desorption/ionization-time of flight
(MALDI-TOF) mass spectrometry spectra were obtained. Peak identification/alignment computer algorithms and
mixed effects models were used to analyze the data.
Results: After analysis of spectra from EAT participants, 24 distinct peaks showed statistically significant differences
associated with cruciferous vegetable intake. Twenty of these peaks were driven by their GSTM1 genotype (i.e.,
GSTM1+ or GSTM1- null). When data from EAT and 2EAT participants were compared by joint processing of spectra
to align a common set, 6 peaks showed consistent changes in both studies in a genotype-dependent manner. The
peaks at 6700 m/z and 9565 m/z were identified as an isoform of transthyretin (TTR) and a fragment of zinc a2-
glycoprotein (ZAG), respectively.
Conclusions: Cruciferous vegetable intake in GSTM1+ individuals led to changes in circulating levels of several
peptides/proteins, including TTR and a fragment of ZAG. TTR is a known marker of nutritional status and ZAG is an
adipokine that plays a role in lipid mobilization. The results of this study present evidence that the GSTM1-
genotype modulates the physiological response to cruciferous vegetable intake.
Background
Intake of vegetables from the family Brassicaceae (i.e.,
cruciferous or broccoli-family) is inversely associated
with the risk of several cancers [1]. The influence of
cruciferous vegetable intake on cancer risk has been
hypothesized to be through several mechanisms, includ-
ing reduction in systemic oxidative stress [2],
suppression of mutagenic and carcinogenic activity [3,4],
reduction in proliferation [5,6] and induction of phase II
detoxifying enzymes, such as glutathione S-transferases
(GST) and UDP-glucuronosyltransferases (UGT) [7,8].
Glucosinolates in cruciferous vegetables that can be
hydrolyzed to yield isothiocyanates (ITC) and indole-3-
carbinol are hypothesized to be the major bioactive con-
stituents contributing to these cancer-preventive effects.
ITC are metabolized through the mercapturic acid
pathway, with GST conjugation of ITC and glutathione
as the first step in the pathway toward degradation [9].
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ticularly GSTM1 [10]. A homozygous deletion of the
GSTM1 gene results in no detectable GSTM1 activity.
Hence, GSTM1-null individuals may have greater expo-
sure to ITC [11], although pharmacokinetic studies do
not conclusively support this concept [12,13]. It is possi-
ble that other GST isozymes may partially compensate
for the lack of GSTM1[14].
Previously, we showed that matrix assisted laser deso-
rption/ionization-time of flight (MALDI-TOF) analysis
of serum proteins could distinguish individuals on the
basis of whether they were consuming controlled diets
devoid of, or supplemented with, cruciferous vegetables;
two specific peptide markers, one of which was the
B-chain of alpha 2-HS glycoprotein (AHSG B-chain),
had the ability to discriminate most accurately between
diets [15]. Here we analyze samples from a more recent
and comprehensive controlled feeding study [8] with the
objectives to: 1) confirm the previous results, 2) evaluate
the dose-response effect of cruciferous vegetables on the
serum peptidome in a separate, independent sample,
and 3) examine the peptidomic response to diet in the
context of GSTM1+ genotype. We hypothesized that,
due to the potential differences in ITC metabolism
between GSTM1+a n dGSTM1-null individuals, the
serum peptidome would differ by genotype. Our results
indicate that GSTM1 genotype differences affect levels
of particular peptides/proteins in a sensitive and specific
manner.
Methods
Research Design
The analyses were conducted using stored serum sam-
ples collected as part of two completed studies, “The
Enzyme Activation Trial” (EAT) [16] and “Enzyme Acti-
vation Trial 2” (2EAT) [8], conducted at the Fred
Hutchinson Cancer Research Center (FHCRC), Seattle,
Washington. These were randomized, crossover, con-
trolled feeding studies designed to test the effects of
vegetable diets and GST genotypes on biotransformation
enzyme activity and other biomarkers of cancer suscept-
ibility. In both studies, participants were recruited and
block randomized to diet order based on GST genotype
and sex [8].
Study Participants
In the EAT study, participants were healthy, non-smo-
kers, aged 20-40 years, and were recruited on the basis
of sex and GSTM1 genotypes. For the current ancillary
study, analyses were conducted on 36 individuals, a sub-
set of the 40 individuals who completed all 4 study peri-
ods and for whom we had sample available: 17 women
(4 GSTM1+a n d1 3GSTM1-null) and 19 men (10
GSTM1+ and 9 GSTM1-null) [16] (Table 1).
In the 2EAT study, participants were healthy, non-
smokers, aged 20-40 years, and were recruited on the
basis of sex and CYP1A2 and GSTM1 genotypes as
described previously [8]. In all, 72 individuals ultimately
were randomized into the parent study; however, for
our current analysis, only samples and data from the
first 42 individuals were included. The distribution of
genotype among these 42 individuals was as follows: 17
women (10 GSTM1+a n d7GSTM1-null)a n d2 5m e n
(10 GSTM1+a n d1 5GSTM1-null) (Table 1). The Insti-
tutional Review Board at the FHCRC approved the stu-
dies and informed written consent was obtained from
all participants prior to the start of these studies.
Study Diets
The EAT and 2EAT studies were conducted as rando-
mized, controlled feeding studies. Study diets were pre-
pared by the FHCRC Human Nutrition Lab. Dinner
was served in the Human Nutrition Lab dining room
Sunday through Friday evening, and food for the fol-
lowing day’s morning, midday meal, and snacks was
d i s t r i b u t e da tt h a tt i m e .O nF r i d a ye v e n i n g ,p a r t i c i -
pants picked up food for Saturday and Sunday meals.
The major portion of the test vegetables was provided
as part of the dinner under the supervision of the
study staff. Participants were instructed to consume
only the food and beverages provided for them during
the diet periods. They were requested not to take any
medication, alcoholic beverages, or nutritional supple-
ments and to maintain their usual physical activity
during each period. Any food not consumed was
recorded on the participant’s chart. Compliance with
the study diet and deviations from the diet were moni-
tored using daily food check-off forms.
In the EAT feeding study, participants consumed four
different controlled diets: (i) a basal diet devoid of fruit
and vegetables; (ii) the basal diet supplemented with a
prescribed amount of cruciferous vegetables (436 g/day
of a mixture of broccoli, cabbage, cauliflower and radish
sprouts); (iii) the basal diet supplemented with allium
vegetables (90 g/day of a mixture of chives, leeks, garlic
and onions); (iv) and the basal diet supplemented with
apiaceous vegetables (270 g/day of a mixture of carrots,
celery, dill weed, parsley and parsnips) [16,17]. Designed
Table 1 Gender and genotype distribution of participants
for EAT and 2EAT
1
Men Women
GSTM1+ (n) GSTM1- (n) GSTM1+ (n) GSTM1- (n)
EAT Study 10 9 4 13
2EAT Study 10 15 10 7
1GSTM1 genotypes (i.e., GSTM1+ or GSTM1- null) by gender are presented for
both dietary studies; all participants were used for analysis.
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enzymes, each of the four diet periods lasted 6 days
with at least a 2 week washout period between diets.
Biotransformation enzymes respond rapidly to diet [18]
and ITC doses are cleared in urine in 24 hours [12],
supporting the lengths of the treatment periods and
washouts. In this study, all individuals received the same
doses of vegetables [16,17].
In the 2EAT feeding study, participants consumed
four different controlled diets: (i) a basal diet devoid of
fruit and vegetables; (ii) the basal diet supplemented
with a prescribed amount of cruciferous vegetables [sin-
gle-dose (1X) cruciferous diet, 7 g/kg-body-weight of a
mixture of broccoli, cabbage, cauliflower and radish
sprouts]; (iii) the basal diet supplemented with twice
this amount of cruciferous vegetables [double-dose (2X)
cruciferous diet, 14 g/kg body weight]; (iv) and the basal
diet supplemented with 7 g cruciferous vegetables/kg
body weight and 4 g apiaceous vegetables/kg body
weight (1X cruciferous plus apiaceous vegetable diet; the
apiaceous vegetables include a mix of carrots, celery, dill
weed, parsley and parsnips) [8]. Diet order was ran-
domly assigned in the cross-over design and controlled
for in the analysis. Each of the four diet periods lasted
14 days with at least a 21 day washout period between
diets and as indicated, vegetables were dosed by body
weight [8].
Our initial mass spectrometry analysis indicated that
the largest differences were between the cruciferous and
basal diets, so the apiaceous and allium vegetable diets
(from EAT, diet iii and iv; from 2EAT, diet iv) were not
included in further analyses [15].
Specimen collection
For the EAT study, blood samples obtained on the last
day (day 7) of each feeding period were used for this
analysis. Blood was drawn in the morning following an
8-12 hour overnight fast. Blood was allowed to clot at
room temperature for 30 min before it was centrifuged
to separate the serum. Serum was aliquotted and stored
at -80°C [16]. For the 2EAT study, blood was collected
from participants on days 0, 7, 11 and day 15 of each
feeding period; only samples from day 15 of the basal
and 2 cruciferous vegetable diets were used for this ana-
l y s i s .B l o o dw a sd r a w ni nt h em o r n i n ga f t e ra1 2h o u r ,
overnight fast and serum obtained, aliquoted and stored
as for the EAT study [8,16,17]. GSTM1 genotyping was
conducted on buccal cell DNA as described previously
[8,19].
Sample Preparation
Highly abundant serum proteins, such as albumin and
IgG, can cause crystallization defects and reduce the
flight of low abundant proteins and peptides in TOF
analyses. Therefore, after evaluating a number of meth-
ods, we chose a commonly used method to precipitate
large globular proteins by mixing 25 uL serum 1:1 with
100% acetonitrile (AcN), shaking on a Vortex Genie 2
(Scientific Industries, Inc., Bohemia, NY) for 30 min and
centrifugation [15]. Supernatant was mixed 1:1 with
4-hydroxy-3,5-dimethoxycinnamic acid (sinapic acid)
matrix (Sigma-Aldrich, St. Louis, MO) and 1 μLw a s
spotted onto a hydrophobic 384 well MALDI plate in
quintuplicate.
Mass Spectrometry
Samples were analyzed using MALDI-TOF MS on an
Applied Biosystem Voyager DE-Pro spectrometer (Fos-
ter City, CA). Daily machine calibrations were per-
formed using cytochrome c [12361 (+1), 6181 (+2)] to
obtain mass accuracy. Plates were analyzed in linear
mode using a 337 nm nitrogen laser, under the follow-
ing settings optimized using cytochrome c: laser inten-
sity 1,784; accelerating voltage 25,000; grid voltage
23,000; guide wire voltage 1,250; delay time 325 ns; low
mass gate 1,000; molecular mass range 1,000-40,000.
Final spectra were generated by summing spectra pro-
duced from 20 laser hits at up to 20 places per spot (a
total of up to 400 laser hits per summed spectra).
Peak Identification and Alignment
To allow for direct comparison, the two datasets were
aligned and processed to formulate a common set of
peaks among spectra using procedures as previously
described [20]. The intensity values of the resulting
aligned peaks were then transformed and standardized
as previously described [21,22].
Briefly, an intensity value, Yijk for subject i, spectrum j
at peak k, was transformed to Tijk =l n ( Yijk - ck +0 . 1 )
where ck is the minimum intensity measured at the k
th
peak among all spectra. The value 0.1 is arbitrary and
included to stabilize the logarithm of any extremely
small value; Yijk-ck was the minimum intensity measured
at the k
th peak among all spectra.
Statistical Analysis
Transformed peak intensities were used in a linear
mixed model that included fixed-effect covariates of sex,
GSTM1 genotype, feeding period, diet treatment, feeding
order and an interaction term between genotype and
diet; a random-effects term for ‘participant’ was included
to accommodate the crossover feeding design. The same
model was used in both EAT and 2EAT feeding studies.
To make these data compatible, it was necessary to
jointly process and align spectra from both studies to
obtain a list of peaks common to both sets of spectra.
The peak intensities at each m/z value in this list were
independently estimated by the back-transformed least
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were consistent in both EAT and 2EAT and, hence,
worthy of further study, we applied the following criter-
ion: (1) the peaks shown to be significant (p < 0.05 from
the linear mixed model) when comparing the ratio of
basal to 1X cruciferous in EAT and 2EAT or the ratio
of basal to 2X cruciferous in 2EAT study; (2) peaks
from step 1 that have similar size in both studies for the
basal and 1X cruciferous diets (EAT has no 2X diet);
(3) peaks from steps 1 and 2 that exhibit the same trend
when comparing basal and 1X cruciferous diets in both
studies. The peaks selected with these criteria were used
for further investigation. All statistical analyses were
performed using the SAS Program (version 9.1; SAS
Institute). Two-sided P-value for statistical significance
was set at < 0.05.
To prevent confounding by body weight between the
sexes in the second study, the amount of vegetables pro-
vided was done on a per-kg body-weight basis, and ran-
ged from 284 g to 662 g for the single-dose cruciferous
diet and 568 g to 1324 g for the double-dose cruciferous
diet. Analyses were conducted both with and without
adjusting for vegetable amount; because there were no
statistically significant differences between the analyses
with and without adjustment, the data are presented
without adjustment.
Analysis of significance for the western and dot blots
was done using linear regression of the average trans-
thyretin (TTR) and zinc a2-glycoprotein (ZAG) levels
associated with cruciferous dose according to genotype,
adjusted for the TTR or ZAG levels from basal feeding
period with robust standard error [23]. In addition, gen-
eralized estimating equations were used with an
exchangeable working correlation structure and averages
were regressed of any level of TTR or ZAG from cruci-
ferous intake on genotype and adjusted for basal levels.
Protein Identification
To identify peptides represented by the statistically sig-
nificant peaks from the MALDI-TOF analysis, albumin
and IgG were removed from the sample via PROT-IA
spin columns (Sigma-Aldrich, St. Louis, MO). Laemmli
sample buffer was added to the eluate and the sample
was heated at 100°C for 5 min. The proteins were sepa-
rated on a NuPAGE 4-12% Bis-Tris Gel (Invitrogen
Corporation, Carlsbad, CA) using 2-(N-morpholino)
ethane sulfonic acid (MES) running buffer (Invitrogen).
The gel was silver stained and bands corresponding to
the correct size were excised. The gel slices were
digested with trypsin in 50 mmol/L ammonium bicarbo-
nate overnight at 37°C. Peptides were extracted from
the gel slice and desalted with a C18 ZipTip (Millipore,
Billerica, MA). The material was then analyzed by nano
LC/MS using a ThermoFisher LTQ (Thermo Fisher
Scientific, Waltham, MA). Proteins were identified using
Xtandem. The database search was performed against
the human IPI database using Protein Prophet. Results
were uploaded to Computational Portal and Analysis
System (CPAS) database and interrogated using the fol-
lowing filters to look for individual proteins or peptides:
Ion Percent ≥ 0.15; +1 Raw Score ≥ 200; + 2 Raw Score
≥ 300; + 3 Raw Score ≥ 300; Unique Peptides > 1.
Fractionation of serum for peptide identification
Control serum (3 mL) was precipitated with an equal
volume of AcN. The protein concentration of the super-
natant from the precipitation was determined using a
BCA Protein Assay (Thermo Fisher Scientific). A total
of 4 mg protein was concentrated to 500 uL in a
Thermo Scientific SpeedVac and loaded onto a Poros
R2/10 RP column (Applied Biosystems) attached to a
Shimadzu SCL-10A liquid chromatograph. Chromato-
graphy was performed at a flow rate of 2.7 mL/min
using aqueous AcN-TFA solvents (buffer A: 5% AcN in
0.1% TFA in water; buffer B: 90% AcN and 0.1% TFA in
10% water). The column was equilibrated at 90% buffer
A. Buffer B was increased to 5% over 10 min, then to
60% over the next 57 min, and finally to 95% in the last
6 min. The column eluate was monitored at 215 and
280 nm. Fractions were collected every 30 sec. All frac-
tions were analyzed via MALDI-TOF to identify those
containing the peptide of interest.
Immunoblot Analyses
For immunoblot analyses, serum samples from the basal
and 2X cruciferous diets for 4 participants in the 2EAT
study were chosen based on high signal-to-noise ratios
in the range of interest. Each sample (25 μL) was preci-
pitated with 25 μL AcN. The protein concentration of
the supernatant from the precipitation was determined
using a BCA Protein Assay (Thermo Fisher Scientific).
Seventy-five micrograms of protein per sample was
boiled for 5 min in 3X sample buffer and separated by
sodium dodecyl sulfate-polyacrylamide gel electrophor-
esis on a 10% gel. Protein was transferred onto nitrocel-
lulose membrane and the membrane was blocked with
5% milk in PBS at room temperature. The blot was
incubated overnight with a TTR antibody (Dako, Car-
pinteria, CA) at 1:500 dilution. Primary antibodies were
visualized with a fluorescent-dye-labeled secondary anti-
body (Alexa Fluor-680 goat anti-rabbit, Molecular
Probes, Eugene, OR) and directly quantified using the
LI-COR Biosciences Odyssey infrared imaging system
(Lincoln, NE) and associated software.
For dot blot analyses, serum samples (1 μL) from each
of the diets for 2EAT participants were spotted in a 96-
well format onto nitrocellulose and the level of TTR or
ZAG was visualized as described above. For ZAG, the
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(R&D Systems, Minneapolis, MN) at 1:250 dilution.
Results
Analysis of diet and genotype in EAT
In the EAT feeding study, participants consumed a basal
diet devoid of fruits and vegetables for 6 days, and, in a
different feeding period, the basal diet supplemented
with cruciferous vegetables (436 g/day of a mixture of
broccoli, cabbage, cauliflower and radish sprouts) also
for 6 days. MALDI-TOF spectra (1,000-40,000 m/z
range) of participant serum were collected for the basal
and cruciferous diets for the 36 study participants in
EAT. A peak alignment and selection algorithm was
applied to the raw spectra and a statistical analysis of
the basal diet versus the cruciferous diet was performed
on the resulting 736 distinct peaks. In Figure 1, we
show an example of a processed MALDI-TOF spectrum
in the 2,500-10,000 m/z range illustrating peak align-
ment and density in this range. The analysis accounted
for the cross-over study design in which each participant
ate both the basal and the cruciferous diet, and
identified 24 statistically significant (P < 0.05) peaks that
differed between the two diets.
Because variation in GST activity has been hypothesized
to influence response to ITC exposure, we investigated the
effect of GSTM1 genotypes on response to diet. Compari-
sons of the basal diet to the cruciferous diet within each
genotype were performed. There were 21 peaks from
GSTM1-null and 39 peaks from GSTM1+ individuals that
changed in a statistically significant manner as a result of
cruciferous vegetable intake. Of the original 24 peaks that
were significant independent of GSTM1 genotype, 20 were
still significant in one genotype or the other. Determina-
tion of the actual relevance of these peaks to cruciferous
diet from these data alone is difficult given that some may
appear significant by chance. Samples from a second diet
study, 2EAT, were used to look for consistent changes in
an independent population to confirm the differences and
the GSTM1 effect.
Analysis of diet and genotype in 2EAT
In the 2EAT feeding study, participants consumed the
c o n t r o l l e dd i e t sf o r1 4d a y s ,a n dw ec o m p a r e d( i )t h e
Figure 1 Processed MALDI-TOF MS spectra. (A) The 2500-10000 m/z range of the log mean spectrum from each study (all spectra from EAT
in red, 2EAT in black) showing the consistency of the data between the two studies and the peak at 7600; (B) A close-up of 2EAT mean
spectrum (in black) with peak-location density histograms from all spectra in each study (EAT in gray, 2EAT in blue) shows there are
approximately 30 peaks in the 9300-10000 range and the ZAG fragment at 9560 m/z appears consistently on the shoulder of the peak at
9520 m/z.
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diet supplemented with a prescribed amount of crucifer-
ous vegetables (7 g/kg body-weight, termed 1X); (iii) the
basal diet supplemented with twice this amount of cru-
ciferous vegetables (14 g/kgb o d y - w e i g h t ,2 X ) .M A L D I -
TOF spectra were collected for each of the diets for the
42 study participants in 2EAT. Peak alignment (coordi-
nated with the EAT data), peak selection and statistical
analysis were carried out as described for the EAT spec-
tra. For the 2X cruciferous diet, the analysis identified
24 statistically significant (P < 0.05) peaks that differed
from the basal diet. Stratifying the 2X data by genotype,
19 of these 24 were still significant in one genotype or
the other. However, independent of these, there were 15
additional peaks that were unique to GSTM1-null indi-
viduals and 23 additional peaks that were unique to
GSTM1+ individuals. In addition to diet, these results
and those from EAT suggest that the serum peptidome
is also being affected by GSTM1 genotype in response
to cruciferous vegetable intake.
Combined analysis of diet and genotype in EAT and 2EAT
We focused our analysis on peptides that showed signif-
icant and directionally consistent changes with a cruci-
ferous diet. Peaks identified to be consistent in both
datasets independent of genotype narrowed the list from
24 in EAT and 2EAT to 4 peaks of interest that shared
significant changes and maintained the same trend and
appropriate intensity change in both sample populations:
4813, 4905, 9565 and 9812 m/z (Table 2).
When we focused the analysis on peaks based on
GSTM1 genotype, two additional peaks of interest were
found to change in a consistent and significant manner in
response to cruciferous vegetable intake: 6500 and
6700 m/z. Further analysis of significance revealed that the
first four peaks shown to be significant by diet were also
driven by the GSTM1+ participants (Table 2). The inten-
sity ratios of all six peaks show that 4905 and 9812 increase
and 4813, 6500, 6500 and 9565 decrease (Table 2).
Identification of 6700 m/z and 9565 m/z as GSTM1+
dependent markers of cruciferous diet
Peaks 6700 m/z and 9565 m/z were selected for identifi-
cation based on the combination of robust intensity
ratios, significance, GSTM1+ regulation, and peak height
(Figure 1). To attempt to obtain identification for these
peaks, the bands of appropriate molecular weights were
excised from a gel and proteins of interest were deter-
mined via Electrospray Ionization (ESI) MS analysis.
A peptide at 6700 m/z found to decrease with crucifer-
ous diet yielded ESI spectra consistent with a fragment
of TTR, a serum protein responsible for the transport of
retinol and the thyroid hormone thyroxine [24,25].
Further, full-length TTR protein has many identified
isoforms at approximately 13,400-14,000 Da [26] which
would appear as 6,600-7,000 peaks as +2 m/z species.
To test whether the peaks seen in these ranges were
TTR, we subjected human sera to C18 HPLC and ana-
lyzed fractions via dot blot analysis using an antibody to
TTR. Dot blot positive HPLC fractions were then exam-
ined via MALDI-TOF MS to identify ones that con-
tained peaks within our range of interest. Fraction 81,
eluting at 27% AcN contained peaks at ~6,700 m/z.W e
also spiked purified TTR into the selected HPLC frac-
tions at various concentrations to see if the MS peaks
would align at similar m/z values. When 50 ug/mL TTR
was spiked into fraction 81, there was alignment of
peaks in the 6600-7000 m/z range including our peak of
interest (data not shown). In these spectra there was evi-
dence of the singly charged form of the TTR isoforms at
13,400-14,000 m/z, further confirming that several peaks
in the 6600-7000 m/z r a n g ew e r el i k e l yt h ed o u b l y
charged forms of TTR.
When we looked at the peak intensity analyses for
EAT and 2EAT presented in a box plot, we see lower
peak heights for 6700 m/z in the GSTM1 genotype with
increasing amounts of cruciferous intake (Figure 2).
Because peak heights may not be directly proportional
to the concentration of a protein/peptide, we performed
a western blot on a subset of individuals in 2EAT using
an antibody to TTR to determine if changes in TTR
were correlated with cruciferous vegetable intake. Rela-
tive to the basal diet, the change in TTR concentration
with feeding the 2X-cruciferous vegetable diet was sig-
nificantly larger among GSTM1+ individuals as com-
pared to GSTM-null individuals, 1.24 ± 0.68 and 0.86 ±
0.26 (mean ratio ± SD), respectively (P = 0.001).
We further investigated a second peptide at 9565 m/z
that was found to decrease with all 3 cruciferous diets
(Table 2). When we present peak intensity analyses for
EAT and 2EAT in a box plot, we see lower peak heights
for 9565 m/z in the GSTM1 genotype with increasing
amounts of cruciferous intake (Figure 3).
In order to obtain possible identifications for this pep-
tide, we excised a band at ~9,500 Da from a gel as indi-
cated above and obtained an ESI spectra consistent with
ZAG, a serum protein that is known to stimulate lipid
degradation in adipocytes [27,28]. Full-length, mature
ZAG protein is a glycoprotein of 38,478 Da, so we are
likely only detecting a fragment of ZAG.
To further test the relationship of 9565 m/z to ZAG,
we subjected human sera to C18 HPLC and analyzed
fractions via dot blot analysis using an antibody to ZAG.
Dot blot positive fractions were then examined via
MALDI-TOF MS to identify ones that contained peaks
within our range of interest. Two HPLC fractions that
contained peaks at ~9500 m/z also showed the most sig-
nal with the ZAG antibody. Thus, two independent
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with 9565 m/z being a fragment of ZAG.
Changes in TTR and ZAG levels by GSTM1 genotype
To further assess the changes in levels of TTR and ZAG,
dot immunoblots of both full sets of EAT and 2EAT
serum samples were performed using antibodies to TTR
and ZAG. A genotype-specific analysis was carried out
on our dot blots to assess the diet differences of TTR and
ZAG levels in GSTM1+ and GSTM1-null individuals.
Among GSTM1+ individuals, the mean TTR signal
decreased in response to cruciferous vegetable intake as
compared to the basal diet (P = 0.030), further support-
ing the western blot and MALDI-TOF results. The dif-
ference between the two genotypes with cruciferous
vegetable intake is statistically significant in the 1X cru-
ciferous diet for EAT (P = 0.033) and the 2X cruciferous
diet for 2EAT (P < 0.001), but the difference was not
significant for the 1X cruciferous diet for 2EAT (P =
0.379). Overall comparison of the two genotypes was
significant (P < 0.001) for cruciferous intake across both
studies (Figure 4).
We then tested whether TTR could classify participants
based on their GSTM1 genotype. For this, we used the
ratio of the TTR levels in the cruciferous versus basal diets
and calculated an ROC curve comparing this ratio’s sensi-
tivity and specificity in distinguishing between GSTM1+
Table 2 Selection of significant peaks affected by diet and/or GSTM1 genotype
1
Peak (m/z) EAT 2EAT
1 X Cruciferous
1 1 X Cruciferous
2 2 X Cruciferous
3
ALL GSTM1-null GSTM1+ ALL GSTM1-null GSTM1+ ALL GSTM1-null GSTM1+
4813 IR
4 0.043 0.370 0.005 0.188 0.254 0.140 0.062 0.478 0.062
p-value 0.047* 0.619 0.031* 0.168 0.427 0.240 0.022* 0.664 0.005*
4905 IR 1.509 1.214 1.877 1.183 0.920 1.521 1.789 1.436 1.789
p-value 0.020* 0.384 0.022* 0.520 0.823 0.248 0.028* 0.326 0.033*
6500 IR 0.870 0.975 0.776 0.823 0.959 0.708 0.527 0.629 0.527
p-value 0.319 0.887 0.242 0.502 0.919 0.391 0.028* 0.248 0.048*
6700 IR 0.782 0.933 0.655 0.712 0.878 0.577 0.574 0.876 0.575
p-value 0.123 0.732 0.087 0.276 0.767 0.207 0.076 0.760 0.029*
9565 IR 0.744 1.229 0.451 0.745 0.966 0.575 0.569 0.629 0.569
p-value 0.044* 0.267 0.001* 0.064 0.879 0.012* 0.000* 0.038* 0.004*
9812 IR 1.218 1.131 1.312 1.167 0.870 1.565 1.494 1.458 1.494
p-value 0.036* 0.297 0.062 0.323 0.529 0.041* 0.011* 0.083 0.058*
11X cruciferous diet (basal diet supplemented with 436 g/day cruciferous vegetables) compared to EAT basal diet (fruit- and vegetable-free).
21X cruciferous diet (basal diet supplemented with 7 g/kg body weight/day cruciferous vegetables) compared to 2EAT basal diet.
32X cruciferous diet (basal diet supplemented with 14 g/kg body weight/day cruciferous vegetables) compared to 2EAT basal diet.
4IR denotes the cruciferous vegetable-to-basal diet peak intensity ratio in the unit of square root of estimand of between-subject variance.
* P < 0.05.
Figure 2 Box plots comparing peak intensities (normalized to
the peak with the highest intensity) of 6700 m/z in EAT and
2EAT. (A) cruciferous vegetable response among GSTM1-null
individuals in EAT. (B) cruciferous vegetable response among GSTM1
+ individuals in EAT. (C) cruciferous vegetable response among
GSTM1-null individuals in 2EAT. (D) Cruciferous vegetable response
among GSTM1+ individuals in 2EAT.
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Page 7 of 11and GSTM1-null. We obtained an area under the curve
(AUC) of 0.79 with optimal sensitivity of 73% and specifi-
city of 75% in the 1X cruciferous diet for EAT. For the 2X
cruciferous diet for 2EAT, the AUC was 0.90 with optimal
sensitivity of 84% and specificity of 100%.
Among GSTM1+ individuals, mean ZAG signal
decreased in response to cruciferous vegetable intake as
compared to the basal diet (P < 0.001). The difference
between the two genotypes with cruciferous vegetable
intake is statistically significant in the 1X cruciferous
diet for EAT (P < 0.001), the 1X cruciferous diet for
2EAT (P < 0.001), and the 2X cruciferous diet for 2EAT
(P < 0.001). Overall comparison of the two genotypes
was significant (P < 0.001) for cruciferous intake across
both studies (Figure 5).
Sensitivity and specificity were calculated for the abil-
ity of ZAG to classify GSTM1 genotype when subjects
ate a cruciferous diet. ZAG has a sensitivity of 100%
and specificity of 100% in all cruciferous diets in both
EAT and 2EAT (AUC=1.00 for all diets in both EAT
and 2EAT).
Discussion
We have demonstrated a GSTM1 genotype-dependent
effect of a cruciferous diet on the proteins found in
human serum using two independent feeding studies,
EAT and 2EAT. We identified two peaks (6700 m/z and
9565 m/z) that were affected by the combination of diet
and GSTM1 g e n o t y p ea n ds h o w e dc o n s i s t e n tt r e n d s
across diets in both studies as a doubly charged isoform
Figure 3 Box plots comparing peak intensities (normalized to the peak with the highest intensity) of 9565 m/z in EAT and 2EAT.
(A) cruciferous vegetable response among GSTM1-null individuals in EAT. (B) cruciferous vegetable response among GSTM1+ individuals in EAT. (C)
cruciferous vegetable response among GSTM1-null individuals in 2EAT. (D) Cruciferous vegetable response among GSTM1+ individuals in 2EAT.
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Using both MALDI-TOF and immunoassays, we
demonstrated that both TTR and ZAG decrease with
cruciferous vegetable intake among GSTM1+ indivi-
duals, but not among individuals with the GSTM1-null
genotype.
TTR is a negative acute-phase protein that decreases in
serum with early signs of inflammation. It is a known mar-
ker of nutritional status and with a half-life of ~2 days, its
concentration closely reflects recent changes in diet
[29,30]. TTR has several known biological roles: In cere-
brospinal fluid, it is a carrier of the thyroid hormone thyr-
oxine (T4) and retinol. In serum, TTR transports 15% of
T4 and retinol through the complex formation with reti-
nol binding protein (RBP). It also binds many aromatic
compounds, leading to speculation of its role in removal
of toxic compounds [24]. Constituents of cruciferous vege-
tables at high doses have been shown to suppress the
function of the thyroid gland [25]. Thus, although the
types and doses of cruciferous vegetables fed in this study
were unlikely to influence thyroid function appreciably,
one possible explanation of our results is that changes in
T4 due to cruciferous vegetable feeding result in less TTR
being needed in serum to aid in transport. Another possi-
ble explanation is that cruciferous vegetable constituents
more directly influence TTR gene expression or TTR pro-
tein half-life through other pathways [31].
ZAG is an adipokine and apparently plays multiple
roles in the human body, most concerning lipid mobili-
zation from fat stores. Levels of ZAG expression are
regulated by glucocorticoids [32]. ZAG is synthesized in
the liver and increased levels correlate with lipolysis
[33], implying that it may be regulated by fat intake.
Decreased levels of ZAG associated with increased cru-
ciferous vegetable intake could relate to adipokine sig-
naling. Another possible explanation is that cruciferous
vegetable constituents directly influence gene expression
as it has been suggested that ZAG expression is likely
mediated by the interaction of several synergistic tran-
scription factors [34]. Investigation into the levels of
other adipokines and further analysis of ZAG processing
will be necessary to shed light on the biology behind
these cruciferous vegetable mediated changes.
These GSTM1-genotype-specific responses of TTR
and ZAG to cruciferous vegetable intake suggest that
differential response to ITC exposure in GSTM1+ and
GSTM1-null individuals may influence the serum pepti-
dome. Whether this genotypic difference is due to a dif-
ference in ITC metabolism [12] or another factor
remains to be determined. To date, studies have not
shown consistent pharmacokinetic differences in ITC
handling by GSTM1 genotype, but given the rather
broad and overlapping substrate specificities of this
superfamily of enzymes, other GST isozymes may com-
pensate in part for the lack of GSTM1 activity [10] or
alternative metabolic pathways may substitute for
GSTM1. By whatever mechanism, several interventions
and observational studies suggest a modifying effect of
GSTM1 genotype on serum GST-a in response to cruci-
ferous vegetable exposure [8,17,35] and as biomarkers of
oxidative damage [36]. Based on this previous work and
our findings here, it appears that this effect may extend
to other serum proteins.
Figure 4 Diet-genotype regulation of mean TTR level
differences via dot blot. Levels of TTR are calculated as a ratio of
cruciferous diet over basal diet for each individual. The values
shown are mean ratio ± SD. Samples analyzed include: EAT N = 36
(14 GSTM1+ and 22 GSTM1-null) and 2EAT N = 42 (20 GSTM1+ and
22 GSTM1-null).
Figure 5 Diet-genotype regulation of mean TTR level
differences via dot blot. Diet-genotype regulation of mean ZAG
level differences via dot blot. Levels of ZAG are calculated as a ratio
of cruciferous diet over basal diet for each individual. The values
shown are mean ratio ± SD. Samples analyzed include: EAT N = 36
(14 GSTM1+ and 22 GSTM1-null) and 2EAT N = 42 (20 GSTM1+ and
22 GSTM1-null).
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controlled study and systematic data analysis, MALDI-
TOF MS is a suitable tool for identifying reproducible
biomarkers that respond to diet. In an earlier MALDI-
TOF MS analysis of the EAT study, a peptide identified
as the B-chain of a2-HS glycoprotein (AHSG) decreased
with cruciferous vegetable intake (p = 0.002) [15]. In the
current 2EAT single-dose cruciferous diet data this pep-
tide showed a similar trend but without statistical signif-
icance (p = 0.197).
The strengths of our study include the controlled
feeding study crossover design, the use of two separate
datasets to examine the consistency of peak changes
across both studies, and the availability of samples from
individuals given two doses of cruciferous vegetables in
2EAT for the assessment of dose-response. Limitations
o ft h i ss t u d yi n c l u d et h em o d e s ts a m p l es i z e s ,w h i c h
limited our power to further stratify the data by sex,
race, genotype and other possibly confounding factors.
Nonetheless, with 78 (36 + 42) participants, we had 80%
power (with Type I error probability of 5%) to detect a
biomarker difference between the cruciferous and basal
diets as small as one-third of its standard deviation. The
two feeding studies were slightly different; the feeding
period length was 6 days for EAT and 14 days for
2EAT. Further, participants were fed amounts of cruci-
ferous vegetables based on their total body weight in
2EAT, but the same, absolute amount in EAT. In 2EAT,
the 2X cruciferous diet also provided doses of crucifer-
ous vegetables that were substantially higher than usual
intake reducing generalizability of the results. To reduce
inherent variability due to sample preparation and
matrix crystallization inconsistencies, samples were run
in quintuplicate with multiple preparations for each
sample. All samples from each individual in the study
were run on the same plate to decrease variability
between plates. All plates were run over the course of
two consecutive days to limit day-to-day and instrument
variability. The peak identification process can be time-
consuming and validation can be costly, hence identify-
ing a large number of significant peaks is challenging.
D e s p i t et h e s ei s s u e s ,w ew e r ea b l et of i n dp e a k sw i t h
consistent changes in response to cruciferous diet.
Further investigation is necessary to establish the
mechanism by which crucifers contribute to these pro-
tein changes in relation to GSTM1 genotype.
Conclusions
In summary, we demonstrated that the serum pepti-
dome is dependent on GSTM1 genotype-diet interac-
tions. Our results support the hypothesis that people of
different GSTM1 genotypes show changes in serum pro-
tein content as a result of metabolic response to diets
high in cruciferous vegetables. We identified two notable
peaks as TTR and ZAG with high sensitivities and spe-
cificities. Particularly for ZAG, these results imply a role
in GSTM1-regulated dietary biomarkers that should be
investigated further. Finally, the study design and the
analytic methods utilized here could be applied more
generally to intervention and observational studies of
genotype-diet interactions.
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